ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com




ÃÀ¸ß÷¼´½«¼ÓÈë2023ÄêÃÀ¹ú°©Ö¢Ñо¿Ð»áÄê»á(American Association for Cancer Research Annual Meeting, AACRÄê»á)¡£¡£¡£¡£¡£±¾½ìÄê»á½«º¸ÇÐí¶àÈÈÃÅ»°Ì⣬£¬£¬£¬£¬£¬°üÀ¨ÃâÒßÖÎÁÆ¡¢»ùÒò±à¼¡¢Ò©ÎïÑо¿ºÍÁÙ´²ÊÔÑéµÈÁìÓòµÄ×îÐÂÏ£ÍûºÍÇ÷ÊÆ¡£¡£¡£¡£¡£ÃÀ¸ß÷ҩÀíҩЧÓëÉúÎﲿ¸±×ܲõ˾²²©Ê¿ÓëÃÀ¸ß÷¹ú¼ÊÑз¢Ð§ÀͲ¿Ö´Ðи±×ܲô÷ѧ¶«²©Ê¿½«ÐͬÃÀ¸ß÷ÃÀ¹úÍŶÓһͬÁÁÏàAACRÄê»áÏÖ³¡(Orange County Convention Center, Orlando, FL)£¬£¬£¬£¬£¬£¬ÌṩЧÀÍչʾºÍ½»Á÷ʱ»ú£¬£¬£¬£¬£¬£¬ÃÀ¸ß÷չλºÅ3047£¬£¬£¬£¬£¬£¬ÆÚ´ýÓëÄúµÄÎîÃæ£¡
ʱ¼ä | 4.14-4.19, 2023
µØµã | ·ðÂÞÀï´ïÖݰÂÀ¼¶à°ÂÀ¼ÖÎÏØ¾Û»áÖÐÐÄ
ÃÀ¸ß÷չλºÅ | #3047
ÃÀ¹ú°©Ö¢Ñо¿Ð»á(AACR)ÊǵÚÒ»¸öÒ²ÊÇ×î´óµÄÖÂÁ¦ÓÚ¼ÓËÙÕ÷·þ°©Ö¢µÄ°©Ö¢Ñо¿×éÖ¯¡£¡£¡£¡£¡£AACRÓÚ1907Äê5ÔÂ7ÈÕÔÚ»ªÊ¢¶ÙÌØÇø½¨É裬£¬£¬£¬£¬£¬ÓÉ11Ãû¶ÔÑо¿¸ÐÐËȤµÄÒ½ÉúºÍ¿ÆÑ§¼Ò×é³É£¬£¬£¬£¬£¬£¬Ö¼ÔÚ¡°½øÒ»³ÌÐò²éºÍÈö²¥°©Ö¢ÖªÊ¶¡±¡£¡£¡£¡£¡£2023 AACRÄê»áÖ÷Ì⣺Advancing the Frontiers of Cancer Science and Medicine£¨Íƽø°©Ö¢¿ÆÑ§ºÍҽѧµÄÇ°ÑØ£©¡£¡£¡£¡£¡£
ÿÄêAACRÄê»áÉ϶¼»áÐû²¼°©Ö¢ÖÎÁÆ×îÐÂÏ£Íû¡£¡£¡£¡£¡£½ñÄ꽫ÔÚ·ðÂÞÀï´ïÖݰÂÀ¼¶àµÄ°ÂÀ¼ÖÎÏØ¾Û»áÖÐÐÄ(4ÔÂ16ÈÕÖÁ19ÈÕÕ¹³ö)ÓëÀ´×ÔÊÀ½ç¸÷µØµÄ2Íò¶àÃû¿ÆÑ§¼ÒºÍÆäËû°©Ö¢×¨ÒµÈËÊ¿ÅöÃæ¡£¡£¡£¡£¡£ÕâЩÓë»áÕßÊÇʵÑéÊÒ¿ÆÑ§¼ÒºÍÁÙ´²Ñо¿Ö°Ô±£¬£¬£¬£¬£¬£¬ËûÃÇרעÓÚ°©Ö¢Ñо¿µÄ¸÷¸ö·½Ã棬£¬£¬£¬£¬£¬°üÀ¨ÊµÑéÖÎÁÆÑ§¡¢·Ö×Ó°ÐÏòÖÎÁÆ¡¢»¯Ñ§¡¢·Ö×ÓÉúÎïѧºÍÒÅ´«Ñ§¡¢ÃâÒßѧºÍÃâÒßÖÎÁÆ¡¢Ö×ÁöÉúÎïѧ¡¢²¡¶¾Ñ§¡¢¶¾Àíѧ¡¢Ô¤·ÀÒÔ¼°ÁÙ´²ºÍת»¯Ñо¿¡£¡£¡£¡£¡£

AACRÕ¹ÌüλÓÚ°ÂÀ¼ÖÎÏØ¾Û»áÖÐÐÄÎ÷Â¥2²ãµÄB¹ÝºÍD¹Ý£¬£¬£¬£¬£¬£¬ÃÀ¸ß÷չ̨λÓÚ×¢²ą́Èë¿Ú´¦£¬£¬£¬£¬£¬£¬Õ¹Î»ºÅ3047¡£¡£¡£¡£¡£
´Ë´ÎAACR¾Û»áÉÏÃÀ¸ß÷´øÀ´2Õź£±¨£¬£¬£¬£¬£¬£¬Õ¹Ê¾ÃÀ¸ß÷ADCºÍPROTACƽ̨µÄǿʢʵÁ¦£º"Evaluation of The Efficacy of ADC Drugs In Vitro & Vivo" ºÍ "Efficacy Studies and PK/PD of PROTAC Drugs In Vitro &Vivo"
ÃÀ¸ß÷ÔÚADCµÄÁÙ´²Ç°Ò»Ì廯Ñо¿¼Æ»®Öƶ©ÖÐÓë¿Í»§ÉîÈë½»Á÷£¬£¬£¬£¬£¬£¬¿ÆÑÐÖ÷¸É½«Ã¿Ò»¸ö°¸ÀýµÄÌØµãÓë¶àÄêʵսÂÄÀúºÍ¼¼Êõ»ýÀÛÏàÁ¬Ïµ£¬£¬£¬£¬£¬£¬ÉóÉ÷µØ½«ÓÅÖÊʵÑ鼯»®ÓëЧ¹ûÌá½»µ½¿Í»§ÊÖÉÏ¡£¡£¡£¡£¡£ÃÀ¸ß÷¿ÉÒÔΪ¿Í»§ÌṩADC Payloads ºÏ³É¡¢ADC ҩЧѧÆÀ¼Û¡¢ADC Ò©´ú¶¯Á¦Ñ§ÆÀ¼ÛºÍADC Çå¾²ÐÔÆÀ¼ÛµÈЧÀÍ¡£¡£¡£¡£¡£×èÖ¹2022Äê⣬£¬£¬£¬£¬£¬ÃÀ¸ß÷ÒÑÀÖ³ÉÖúÁ¦13¸öADCÒ©Îï»ñÅúÁÙ´²£¬£¬£¬£¬£¬£¬²¢ÓÐ10¶à¸öADCÏîÄ¿ÔÚÑС£¡£¡£¡£¡£×èÖ¹ÏÖÔÚ£¬£¬£¬£¬£¬£¬ÃÀ¸ß÷³Ð½ÓµÄINDÉ걨ÀàÉúÎïÒ©´óÏîÄ¿ÒѾ100¶àÏ£¬£¬£¬£¬£¬°üÀ¨µ¥¿¹¡¢Ë«¿¹¡¢¶à¿¹¡¢ADC¡¢²¡¶¾ÒßÃçºÍÈÚºÏÂѰ׵ȡ£¡£¡£¡£¡£
ÃÀ¸ß÷PROTACÒ©Îï·¢Ã÷¼¼Êõƽ̨»ã×ÜÁËÄ¿½ñÊ¢ÐеÄÈÈÃŵİбêÂѰ×ÅäÌ壻£»£»£»½¨ÉèÁËÆÕ±éµÄÈÈÃŰÐÏòÂѰ׸߶ÈÇ׺ÍÁ¦Ð¡·Ö×Ó¼°Ð¡·Ö×ÓÆ¬¶Ï»¯ºÏÎï¿â£¨TPSM£©£¬£¬£¬£¬£¬£¬ÆÕ±éµÄE3ÅþÁ¬Ã¸£¬£¬£¬£¬£¬£¬¸ß¶ÈÇ׺ÍÁ¦µÄС·Ö×Ó¼°Ð¡·Ö×ÓÆ¬¶Ï£¨E3SM£©£»£»£»£»½¨ÉèÁËlinkerϵͳ,°üÀ¨ÍøÂç´ó×Ú¾ßÓÐÆÕ±é¶àÑùÐÔµÄË«¹ÙÄÜÍÅÅþÁ¬Ì壨BF-Linker£©¡£¡£¡£¡£¡£ÕâЩ»ýÀ۵ϝºÏÎï¿â¿ÉÒÔ×ÊÖú¿ìËÙ¸ßЧµÄºÏ³É´ó×ڸ߻îÐÔPROTACË«ÌØÒìÐÔС·Ö×Ó£¬£¬£¬£¬£¬£¬¼«´óµØÌá¸ß½ÓÄÉPROTAC¼¼Êõ¾ÙÐеÄÒ©ÎïÑз¢Àú³Ì¡£¡£¡£¡£¡£³ýÁË¿ìËٺϳÉÖ®Í⣬£¬£¬£¬£¬£¬ÎÒÃÇͬʱ½¨ÉèºÍÍêÉÆµÄPROTACÉúÎïɸѡÓë²âÊÔÆ½Ì¨£¬£¬£¬£¬£¬£¬ºóÐøÉú³¤¹âÁÙ´²Ç°ËùÓн׶Ρ£¡£¡£¡£¡£×èÖ¹2022Äê⣬£¬£¬£¬£¬£¬ÃÀ¸ß÷ÒÑÀÖ³ÉÖúÁ¦3¸öPROTACÒ©Îï»ñÅúÁÙ´²£¬£¬£¬£¬£¬£¬²¢ÓÐ20¶à¸öPROTACÏîÄ¿ÔÚÑС£¡£¡£¡£¡£
Ïà¹ØÐÂÎÅʱ¼ä£º2019Äê3ÔÂ29ÈÕ-4ÔÂ3ÈÕ
ËùÔÚ£ºÃÀ¹ú?×ôÖÎÑÇÖÝ